Valsartan Impurity 224
- CAS1283097-98-2
- CatalogueRS-V011015
- FormulaC24H27N5O3
- MW433.51
BACK ORDER
On this page
Product identification
| Product name | Valsartan Impurity 224 |
|---|---|
| Catalogue No. | RS-V011015 |
| CAS No. | 1283097-98-2 |
| Molecular formula | C24H27N5O3 |
| Molecular weight | 433.51 |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Valsartan |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-V011015 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-V011015 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Valsartan
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-V011015
- Request a quotation for RS-V011015
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Valsartan
All 123 further standards are listed here — every link is in the page, not loaded later.
-
Valsartan
IN STOCKRS-U007011 -
Valsartan EP Impurity B
IN STOCKRS-Z398CF8 -
Valsartan USP Related Compound A
IN STOCKRS-V011007 -
Valsartan Related Compound B (Valsartan EP Impurity C)
IN STOCKRS-V011012 -
((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)valine
CUSTOM SYNTHESISRS-P030076 -
(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpentanoic Acid
IN STOCKRS-D003061 -
(3R,5S)-rel-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-pyrrolidinone
CUSTOM SYNTHESISRS-Z401EZL -
(R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropan-1-ol
IN STOCKRS-P007126 -
(S)-(-)-Valsartan D8 (valine D8)
IN STOCKRS-I102005 -
(S)-methyl 3-methyl-2-pentanamidobutanoate
IN STOCKRS-V011190 -
1-Bromo-4-(ethoxymethyl)benzene
BACK ORDERRS-U005AB7 -
2'-Cyanobiphenyl-3-carboxylic acid
IN STOCKRS-U071216 -
2-(2-cyanophenyl)benzoic Acid
BACK ORDERRS-U006A91 -
3'-(Hydroxymethyl)-[1,1'-biphenyl]-2-carbonitrile
IN STOCKRS-U067757 -
4'-Formyl-[1,1'-biphenyl]-4-carbonitrile
IN STOCKRS-D120028 -
4,4′-Bis(bromomethyl)biphenyl
IN STOCKRS-U005219 -
4-(4-Bromomethylphenyl)benzonitrile
IN STOCKRS-I012231 -
4-(Azidomethyl)-[1,1-Biphenyl]-2-Metanoic Acid
CUSTOM SYNTHESISRS-I004302 -
4-(Bromomethyl)biphenyl
IN STOCKRS-I012194 -
5-(3-Chloropropyl)-1-cyclohexyl-1H-tetrazole
IN STOCKRS-V011040 -
D-Valine Methyl Ester Hydrochloride
IN STOCKRS-U102037 -
ethyl 2-(diphenoxyphosphoryl) propanoate
BACK ORDERRS-U095191 -
H-Lys(Boc)OMe
IN STOCKRS-U050346 -
Isoleucine Valsartan
IN STOCKRS-U011037 -
Methyl 4-amino-3-methyl benzoate
IN STOCKRS-Z401DY5 -
Methyl N-butyryl-N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate
IN STOCKRS-D128144 -
N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-(pent-4-enoyl)-L-valine
BACK ORDERRS-P025242 -
N-(1-Oxopropyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
BACK ORDERRS-I014213 -
N-Ethylisopropylamine
IN STOCKRS-U054170 -
N-Ethylisopropylamine Hydrochloride
IN STOCKRS-P025263 -
N-Nitroso-di-n-butylamine-[D18]
IN STOCKRS-N001114 -
N-Nitroso-di-n-hexylamine Standard
IN STOCKRS-N001285 -
N1-Trityl Valsartan
IN STOCKRS-V011058 -
Nitroso-Phenylethylamine
CUSTOM SYNTHESISRS-N001341 -
rac-Valsartan Ethyl Ester
CUSTOM SYNTHESISRS-V011047 -
Sodium 5-(4'-formyl-[1,1'-biphenyl]-2-yl)tetrazol-2-ide
CUSTOM SYNTHESISRS-Z401M5G -
Tributylstannanylium Azide
CUSTOM SYNTHESISRS-U087545 -
Trityl valsartan methyl ester
BACK ORDERRS-V011056 -
Valeryl Chloride
IN STOCKRS-U007179 -
Valsartan Benzyl Ester N2-Trityl Analog
BACK ORDERRS-V011071 -
Valsartan D4
BACK ORDERRS-V011014 -
Valsartan Desvaleryl Methyl Ester (HCl Salt)
BACK ORDERRS-U007207 -
Valsartan Disodium
IN STOCKRS-V011054 -
Valsartan DP-2 Impurity
CUSTOM SYNTHESISRS-V011016 -
Valsartan Ethyl Ester
IN STOCKRS-U007008 -
Valsartan Methyl Ester
IN STOCKRS-U007012 -
Valsartan Racemic Mixture
BACK ORDERRS-V011061 -
Valsartan Related Compound
CUSTOM SYNTHESISRS-V011068 -
Valsartan-d3
BACK ORDERRS-V011017 -
Valsartan-d9
IN STOCKRS-V011013 -
Valsartan Impurity 1
CUSTOM SYNTHESISRS-V011027 -
Valsartan Impurity 2
CUSTOM SYNTHESISRS-V011033 -
Valsartan Impurity 3 (Sodium Salt)
IN STOCKRS-V011041 -
Valsartan Impurity 4
IN STOCKRS-V011005 -
Valsartan Impurity 5
IN STOCKRS-V011011 -
Valsartan Impurity 9
IN STOCKRS-V011009 -
Valsartan Impurity 10
IN STOCKRS-V011006 -
Valsartan Impurity 12
IN STOCKRS-V011003 -
Valsartan Impurity 14
IN STOCKRS-V011034 -
Valsartan Impurity 15 HCl
IN STOCKRS-V011010 -
Valsartan Impurity 17 Monomer
IN STOCKRS-V011023 -
Valsartan Impurity 18
IN STOCKRS-V011002 -
Valsartan Impurity 19-13C,d6 (N-Nitroso Dimethylamine-13C,d6)
IN STOCKRS-V011049 -
Valsartan Impurity 23
IN STOCKRS-V011028 -
Valsartan Impurity 30
IN STOCKRS-U015098 -
Valsartan Impurity 31
BACK ORDERRS-V011048 -
Valsartan Impurity 32
BACK ORDERRS-I001B7Y -
Losartan Potassium Impurity 5 (Losartan Potassium EP Impurity E)
IN STOCKRS-V011004 -
Valsartan Impurity 44(Hydrochloride)
IN STOCKRS-V011030 -
Valsartan Impurity 45
IN STOCKRS-V011019 -
Valsartan Impurity 49
BACK ORDERRS-V011022 -
Valsartan Impurity 52
CUSTOM SYNTHESISRS-V011018 -
Valsartan Impurity 56
BACK ORDERRS-V011064 -
Valsartan Impurity 58
IN STOCKRS-V011020 -
Valsartan Impurity 60
CUSTOM SYNTHESISRS-V011065 -
Valsartan Impurity 61
CUSTOM SYNTHESISRS-V011066 -
Valsartan Impurity 73
IN STOCKRS-V011038 -
Valsartan Impurity 74
BACK ORDERRS-V011021 -
Valsartan Impurity 77
BACK ORDERRS-I001BSK -
Valsartan Impurity 78
BACK ORDERRS-V011060 -
Valsartan Impurity 81
BACK ORDERRS-I001BNE -
Valsartan Impurity 83 Monomer
IN STOCKRS-V011025 -
Valsartan Impurity 90
IN STOCKRS-V011026 -
Valsartan Impurity 98
CUSTOM SYNTHESISRS-Z401GEA -
Valsartan Impurity 112 (N-Nitroso Valsartan Impurity 111)
IN STOCKRS-V011052 -
Valsartan Impurity 113
BACK ORDERRS-Z398CF9 -
Valsartan Impurity 119
CUSTOM SYNTHESISRS-V011051 -
Valsartan Impurity 122
BACK ORDERRS-I001ADJ -
Valsartan Impurity 123
BACK ORDERRS-Z400ER1 -
Valsartan Impurity 127
CUSTOM SYNTHESISRS-I001A0A -
Valsartan Impurity 130
IN STOCKRS-V011029 -
Valsartan Impurity 137
IN STOCKRS-I001BW9 -
Valsartan Impurity 140
BACK ORDERRS-I001AJK -
Valsartan Impurity 143
IN STOCKRS-I001A8M -
Valsartan Impurity 157
IN STOCKRS-V011069 -
Valsartan Impurity 166
BACK ORDERRS-V011078 -
Valsartan Impurity 171;Sacubitril Impurity 72
CUSTOM SYNTHESISRS-V011079 -
Valsartan Impurity 175
BACK ORDERRS-V011031 -
Valsartan Impurity 190
IN STOCKRS-V011032 -
Valsartan Impurity 191
IN STOCKRS-V011039 -
Valsartan Impurity 192
IN STOCKRS-V011043 -
Valsartan Impurity 193
CUSTOM SYNTHESISRS-V011044 -
Valsartan Impurity 194
BACK ORDERRS-V011055 -
Valsartan Impurity 222
IN STOCKRS-U006155 -
Valsartan Impurity 223
IN STOCKRS-V011001 -
Valsartan Impurity 225
BACK ORDERRS-V011024 -
Valsartan Impurity 226
IN STOCKRS-V011035 -
Valsartan Impurity 227
IN STOCKRS-V011036 -
Valsartan Impurity 228
IN STOCKRS-V011037 -
Valsartan Impurity 229
BACK ORDERRS-V011045 -
Valsartan Impurity 230
BACK ORDERRS-V011046 -
Valsartan Impurity 231
IN STOCKRS-V011050 -
Valsartan Impurity 232
IN STOCKRS-V011053 -
Valsartan Impurity 233
BACK ORDERRS-V011059 -
Valsartan Impurity 234
BACK ORDERRS-V011062 -
Valsartan Impurity 235
BACK ORDERRS-V011063 -
Valsartan Impurity 236
IN STOCKRS-V011067 -
Valsartan Impurity 237
IN STOCKRS-V011070 -
Valsartan Impurity 269
BACK ORDERRS-V011075 -
Valsartan Impurity 270
IN STOCKRS-V011076
![Chemical structure of ((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)valine](/structures/w4/NSXSCTCKWRSTHJ-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-amino-2-methylpentanoic Acid](/structures/w4/WQQLDAFJPWYZCC-DYVFJYSZSA-N.webp?v=8)
![Chemical structure of (3R,5S)-rel-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-pyrrolidinone](/structures/w4/AQZMTUIKFVQARJ-LYSZQXJVSA-N.webp?v=8)
![Chemical structure of (R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropan-1-ol](/structures/w4/RCAIWVIQRMDTAV-OAHLLOKOSA-N.webp?v=8)
![Chemical structure of (S)-Benzyl 2-(N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate](/structures/w4/AYZFVKWRZGNQNU-PMERELPUSA-N.webp?v=8)
![Chemical structure of 3'-(Hydroxymethyl)-[1,1'-biphenyl]-2-carbonitrile](/structures/w4/DMCGDTBCCNVQGQ-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4'-Formyl-[1,1'-biphenyl]-4-carbonitrile](/structures/w4/RCQRVCXPHMXSRD-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 4-(Azidomethyl)-[1,1-Biphenyl]-2-Metanoic Acid](/structures/w4/MVWDXKSLZOABLI-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of Methyl N-butyryl-N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valinate](/structures/w4/WXPIQSBBMARQSW-QHCPKHFHSA-N.webp?v=8)
![Chemical structure of N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-(pent-4-enoyl)-L-valine](/structures/w4/JGXVCPPNGBWLGQ-QFIPXVFZSA-N.webp?v=8)
![Chemical structure of N-(1-Oxopropyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine](/structures/w4/ZKBGUUWWEGXVJV-FQEVSTJZSA-N.webp?v=8)
![Chemical structure of N-Nitroso-di-n-butylamine-[D18]](/structures/w4/YGJHZCLPZAZIHH-VAZJTQEUSA-N.webp?v=8)
![Chemical structure of rel-4-((3R,5S)-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl)-4-oxobutanoic Acid](/structures/w4/VWCKXAQRSUUVFU-BEFAXECRSA-N.webp?v=8)
![Chemical structure of Sodium 5-(4'-formyl-[1,1'-biphenyl]-2-yl)tetrazol-2-ide](/structures/w4/GGKVXPUNNCZJKN-UHFFFAOYSA-O.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.